Biotech
STAT+: Immunovant shares surge on arthritis trial data
Trial results for Lilly's "triple-G" drug, FDA's leadership purge leaves chaos, and more biotech news from The Readout
This browser does not support voice playback. Try Chrome, Edge or Safari.